Research work · 2016
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp
The Lancet
Research work · 2016
Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp
The Lancet